Sign In

Devon K. Check, PhD

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3465 (phone)
devon.k.check@kp.org


 
Devon Check, PhD, is an adjunt investigator at the Kaiser Permanente Northern California Division of Research. Devon received her bachelor's degree in History and Spanish from the University of Virginia, and her PhD in Health Policy and Management from the University of North Carolina at Chapel Hill. During her PhD program, she was supported by a National Cancer Institute-sponsored traineeship in cancer care quality research. Her dissertation investigated racial disparities in the quality of chemotherapy-induced side effect management among women being treated for breast cancer. Dr. Check's current research focuses broadly on improving the quality, value, and equity of cancer care.

Current Position(s):

  • Adjunct Investigator, Division of Research, Kaiser Permanente Northern California

Section Affiliations:

Primary Research Interests:

  • Health services research
  • Cancer care quality and outcomes research
  • Variation in cancer care delivery
  • Improving value in cancer care
  • Disparities in patient experiences and outcomes

    No results found matching criteria
    No results found matching criteria

    Perioperative Intravesical Chemotherapy for Patients WithNon-Muscle-invasive Bladder Cancer: Understanding the Extent of and Sources of Variation in Guideline-recommended Use.

    Author(s): Check, Devon K; Aaronson, David S; Nielsen, Matthew E; Lee, Valerie S; Ergas, Isaac J; Roh, Janise M; Kushi, Lawrence H; Tang, Li; Kwan, Marilyn L

    Urology. 2019 Feb;124:107-112. doi: 10.1016/j.urology.2018.10.016. Epub 2018 Oct 23.

    PubMed abstract

    Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions.

    Author(s): Check, Devon K; Chawla, Neetu; Kwan, Marilyn L; Pinheiro, Laura; Roh, Janise M; Ergas, Isaac J; Stewart, Anita L; Kolevska, Tatjana; Ambrosone, Christine; Kushi, Lawrence H

    Breast Cancer Res Treat. 2018 Aug;170(3):593-603. doi: 10.1007/s10549-018-4776-0. Epub 2018 Apr 5.

    PubMed abstract

    Appropriate Use of Antiemetics to Prevent Chemotherapy-Induced Nausea and Vomiting

    Author(s): Check DK; Basch EM

    JAMA Oncol. 2016 Sep 15.

    PubMed abstract

    Early supportive medication use and end-of-life care among Medicare beneficiaries with advanced breast cancer

    Author(s): Check DK; Rosenstein DL; Dusetzina SB

    ​Support Care Cancer. 2016 Aug;24(8):3463-72. doi: 10.1007/s00520-016-3174-6. Epub 2016 Mar 19.

    PubMed abstract

    Parenting concerns, quality of life, and psychological distress in patients with advanced cancer

    Author(s): Park EM; Deal AM; Check DK; Hanson LC; Reeder-Hayes KE; Mayer DK; Yopp JM; Song MK; Muriel AC; Rosenstein DL

    ​Psychooncology. 2016 Aug;25(8):942-8. doi: 10.1002/pon.3935. Epub 2015 Aug 17.

    PubMed abstract

    Examining racial variation in antiemetic use and post-chemotherapy health care utilization for nausea and vomiting among breast cancer patients

    Author(s): Check DK; Reeder-Hayes KE; Zullig LL; Weinberger M; Basch EM; Dusetzina SB

    Support Care Cancer. 2016 Jul 27.

    PubMed abstract

    Investigation of Racial Disparities in Early Supportive Medication Use and End-of-Life Care Among Medicare Beneficiaries With Stage IV Breast Cancer

    Author(s): Check DK; Samuel CA; Rosenstein DL; Dusetzina SB

    ​J Clin Oncol. 2016 Jul 1;34(19):2265-70. doi: 10.1200/JCO.2015.64.8162. Epub 2016 May 9.

    PubMed abstract

    Concerns underlying treatment preferences of advanced cancer patients with children

    Author(s): Check DK; Park EM; Reeder-Hayes KE; Mayer DK; Deal AM; Yopp JM; Rosenstein DL; Hanson LC

    ​Psychooncology. 2016 May 26. doi: 10.1002/pon.4164. [Epub ahead of print]

    PubMed abstract

    Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer

    Author(s): Check DK; Reeder-Hayes KE; Basch EM; Zullig LL; Weinberger M; Dusetzina SB

    ​Breast Cancer Res Treat. 2016 Apr;156(2):351-9. doi: 10.1007/s10549-016-3747-6. Epub 2016 Mar 11.

    PubMed abstract

    An exploratory study of end-of-life prognostic communication needs as reported by widowed fathers due to cancer

    Author(s): Park EM; Check DK; Yopp JM; Deal AM; Edwards TP; Rosenstein DL

    ​Psychooncology. 2015 Nov;24(11):1471-6. doi: 10.1002/pon.3757. Epub 2015 Feb 6.

    PubMed abstract

    Is there a role for survivorship care plans in advanced cancer?

    Author(s): Mayer DK; Green M; Check DK; Gerstel A; Chen RC; Asher G; Wheeler SB; Hanson LC; Rosenstein DL

    ​Support Care Cancer. 2015 Aug;23(8):2225-30. doi: 10.1007/s00520-014-2586-4. Epub 2015 Jan 7.

    PubMed abstract

    Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013)

    Author(s): Mayer DK; Birken SA; Check DK; Chen RC

    ​Cancer. 2015 Apr 1;121(7):978-96. doi: 10.1002/cncr.28884. Epub 2014 Sep 23.

    PubMed abstract